172 related articles for article (PubMed ID: 15725810)
1. Immunohistochemical analysis of novel monoclonal antibody PNL2 and comparison with other melanocyte differentiation markers.
Busam KJ; Kucukgöl D; Sato E; Frosina D; Teruya-Feldstein J; Jungbluth AA
Am J Surg Pathol; 2005 Mar; 29(3):400-6. PubMed ID: 15725810
[TBL] [Abstract][Full Text] [Related]
2. KBA62 and PNL2: 2 new melanoma markers-immunohistochemical analysis of 1563 tumors including metastatic, desmoplastic, and mucosal melanomas and their mimics.
Aung PP; Sarlomo-Rikala M; Lasota J; Lai JP; Wang ZF; Miettinen M
Am J Surg Pathol; 2012 Feb; 36(2):265-72. PubMed ID: 22067329
[TBL] [Abstract][Full Text] [Related]
3. A103: An anti-melan-a monoclonal antibody for the detection of malignant melanoma in paraffin-embedded tissues.
Jungbluth AA; Busam KJ; Gerald WL; Stockert E; Coplan KA; Iversen K; MacGregor DP; Old LJ; Chen YT
Am J Surg Pathol; 1998 May; 22(5):595-602. PubMed ID: 9591730
[TBL] [Abstract][Full Text] [Related]
4. The usefulness of tyrosinase in the immunohistochemical assessment of melanocytic lesions: a comparison of the novel T311 antibody (anti-tyrosinase) with S-100, HMB45, and A103 (anti-melan-A).
Clarkson KS; Sturdgess IC; Molyneux AJ
J Clin Pathol; 2001 Mar; 54(3):196-200. PubMed ID: 11253130
[TBL] [Abstract][Full Text] [Related]
5. Microphthalmia transcription factor expression in cutaneous benign, malignant melanocytic, and nonmelanocytic tumors.
King R; Googe PB; Weilbaecher KN; Mihm MC; Fisher DE
Am J Surg Pathol; 2001 Jan; 25(1):51-7. PubMed ID: 11145251
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical investigation of PNL2 reactivity of canine melanocytic neoplasms and comparison with Melan A.
Giudice C; Ceciliani F; Rondena M; Stefanello D; Grieco V
J Vet Diagn Invest; 2010 May; 22(3):389-94. PubMed ID: 20453212
[TBL] [Abstract][Full Text] [Related]
7. PNL2, a new monoclonal antibody directed against a fixative-resistant melanocyte antigen.
Rochaix P; Lacroix-Triki M; Lamant L; Pichereaux C; Valmary S; Puente E; Al Saati T; Monsarrat B; Susini C; Buscail L; Delsol G; Voigt JJ
Mod Pathol; 2003 May; 16(5):481-90. PubMed ID: 12748255
[TBL] [Abstract][Full Text] [Related]
8. Microphthalmia transcription factor in the immunohistochemical diagnosis of metastatic melanoma: comparison with four other melanoma markers.
Miettinen M; Fernandez M; Franssila K; Gatalica Z; Lasota J; Sarlomo-Rikala M
Am J Surg Pathol; 2001 Feb; 25(2):205-11. PubMed ID: 11176069
[TBL] [Abstract][Full Text] [Related]
9. Expression of melan-A (MART1) in benign melanocytic nevi and primary cutaneous malignant melanoma.
Busam KJ; Chen YT; Old LJ; Stockert E; Iversen K; Coplan KA; Rosai J; Barnhill RL; Jungbluth AA
Am J Surg Pathol; 1998 Aug; 22(8):976-82. PubMed ID: 9706977
[TBL] [Abstract][Full Text] [Related]
10. Protein Expression Analysis of Melanocyte Differentiation Antigen TRP-2.
Avogadri F; Gnjatic S; Tassello J; Frosina D; Hanson N; Laudenbach M; Ritter E; Merghoub T; Busam KJ; Jungbluth AA
Am J Dermatopathol; 2016 Mar; 38(3):201-7. PubMed ID: 26894771
[TBL] [Abstract][Full Text] [Related]
11. PNL2: an adjunctive biomarker for renal angiomyolipomas and perivascular epithelioid cell tumours.
Gulavita P; Fletcher CDM; Hirsch MS
Histopathology; 2018 Feb; 72(3):441-448. PubMed ID: 28837273
[TBL] [Abstract][Full Text] [Related]
12. Immunoprofile of MITF, tyrosinase, melan-A, and MAGE-1 in HMB45-negative melanomas.
Xu X; Chu AY; Pasha TL; Elder DE; Zhang PJ
Am J Surg Pathol; 2002 Jan; 26(1):82-7. PubMed ID: 11756773
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical identification of canine melanocytic neoplasms with antibodies to melanocytic antigen PNL2 and tyrosinase: comparison with Melan A.
Ramos-Vara JA; Miller MA
Vet Pathol; 2011 Mar; 48(2):443-50. PubMed ID: 20858741
[TBL] [Abstract][Full Text] [Related]
14. T311--an anti-tyrosinase monoclonal antibody for the detection of melanocytic lesions in paraffin embedded tissues.
Jungbluth AA; Iversen K; Coplan K; Kolb D; Stockert E; Chen YT; Old LJ; Busam K
Pathol Res Pract; 2000; 196(4):235-42. PubMed ID: 10782467
[TBL] [Abstract][Full Text] [Related]
15. Expression of melanocytic differentiation markers in malignant melanomas of the oral and sinonasal mucosa.
Prasad ML; Jungbluth AA; Iversen K; Huvos AG; Busam KJ
Am J Surg Pathol; 2001 Jun; 25(6):782-7. PubMed ID: 11395556
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical expression of melanocytic antigen PNL2, Melan A, S100, and PGP 9.5 in equine melanocytic neoplasms.
Ramos-Vara JA; Frank CB; DuSold D; Miller MA
Vet Pathol; 2014 Jan; 51(1):161-6. PubMed ID: 23370093
[TBL] [Abstract][Full Text] [Related]
17. Analysis of microphthalmia transcription factor expression in normal tissues and tumors, and comparison of its expression with S-100 protein, gp100, and tyrosinase in desmoplastic malignant melanoma.
Busam KJ; Iversen K; Coplan KC; Jungbluth AA
Am J Surg Pathol; 2001 Feb; 25(2):197-204. PubMed ID: 11176068
[TBL] [Abstract][Full Text] [Related]
18. Actin-binding protein expression in benign and malignant melanocytic proliferations.
Bouffard D; Duncan LM; Howard CA; Mihm MC; Byers HR
Hum Pathol; 1994 Jul; 25(7):709-14. PubMed ID: 8026830
[TBL] [Abstract][Full Text] [Related]
19. Serological reagents for the immunohistochemical analysis of melanoma metastases in sentinel lymph nodes.
Jungbluth AA
Semin Diagn Pathol; 2008 May; 25(2):120-5. PubMed ID: 18697716
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical and reverse transcription-polymerase chain reaction expression analysis of tyrosinase and microphthalmia-associated transcription factor in angiomyolipomas.
Jungbluth AA; King R; Fisher DE; Iversen K; Coplan K; Kolb D; Williamson B; Chen YT; Stockert E; Old LJ; Busam KJ
Appl Immunohistochem Mol Morphol; 2001 Mar; 9(1):29-34. PubMed ID: 11277411
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
